|
KIF3C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.50199999999967E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.168000E-04 |
| Normal-vs-Stage2 |
2.491800E-02 |
| Normal-vs-Stage3 |
4.384400E-04 |
| Normal-vs-Stage4 |
5.37709999970382E-07 |
| Stage1-vs-Stage2 |
8.292000E-01 |
| Stage1-vs-Stage3 |
6.114600E-01 |
| Stage1-vs-Stage4 |
9.797100E-03 |
| Stage2-vs-Stage3 |
9.008000E-01 |
| Stage2-vs-Stage4 |
1.328570E-01 |
| Stage3-vs-Stage4 |
6.244100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.579300E-04 |
| Normal-vs-AfricanAmerican |
7.209000E-01 |
| Normal-vs-Asian |
1.464480E-02 |
| Caucasian-vs-AfricanAmerican |
4.306400E-01 |
| Caucasian-vs-Asian |
9.643400E-01 |
| AfricanAmerican-vs-Asian |
4.462800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.08370000000158E-05 |
| Normal-vs-Female |
1.249570E-04 |
| Male-vs-Female |
3.803800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.755840E-03 |
| Normal-vs-Age(41-60Yrs) |
4.811200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.5386899999914E-05 |
| Normal-vs-Age(81-100Yrs) |
1.350560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.597200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.037220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.014600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.631230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.691200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.330000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.742400E-01 |
| Classical-VS-Follicular |
1.724370E-01 |
| Classical-VS-Other |
3.143800E-01 |
| Classical-VS-Normal |
5.589300E-04 |
| Tall-VS-Follicular |
5.441800E-01 |
| Tall-VS-Other |
4.676000E-01 |
| Tall-VS-Normal |
9.240600E-03 |
| Follicular-VS-Other |
7.664200E-01 |
| Follicular-VS-Normal |
5.236500E-04 |
| Other-VS-Normal |
1.140480E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.95930000000044E-05 |
| Normal-vs-N1 |
1.50922999999636E-05 |
| N0-vs-N1 |
2.268800E-01 |
|
|
